Bio-IT World August 23, 2024

Contributed Commentary by Stef van Grieken, Co-Founder & CEO of Cradle

August 23, 2024 | The biotech industry is experiencing a significant shift as technology and biology converge. This intersection, often called Techbio, is opening up new possibilities for addressing health and environmental challenges. To harness these opportunities, companies need to build teams that can bridge the gap between scientific knowledge and technological innovation.

Understanding Different Perspectives (And Why We Need Both)

Traditionally, scientists and engineers have been seen as having distinct approaches to problem-solving.

Scientists are often driven by the pursuit of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article